AR and prostate cancer: In AR-positive cells, a higher expression of miR-17-92a is observed compared to AR-negative cells and ectopic expression of AR could enhance the expression of miR-17-92a cluster in AR-negative prostate cancer cells while knockdown of AR decreased miR-17-92a expression in AR-positive cells [54].